Israel captures Syrian territory after Assad regime collapse Ivar AI

Ambcrypto.com

Crypto market cap surpasses France, UK GDPs – India, Japan next

Biztoc.com

Google parent Alphabet’s shares surge after quantum computing breakthrough

The Atlantic

Khamenei Loses Everything

Www.abc.es

Las empresas constructoras españolas solidifican su sueño americano

Biztoc.com

Taiwan Semi November Revenue Ups 34% Strengthened by AI and Smartphone Demand

Decrypt

Google’s New Willow Chip Accelerates Time to Market for Quantum Computing, Experts Say

The Daily Caller

US, Israel Conduct Over 75 Strikes In Wake Of Syria’s Regime Collapse

The Daily Hodl

Crypto Investment Products Break Previous Record With $3,850,000,000 in Weekly Inflows: CoinShares

CNBC

Stock market today: Live updates

ETF Daily News

JPMorgan Chase & Co. Forecasts Strong Price Appreciation for Lululemon Athletica (NASDAQ:LULU) Stock

La Vanguardia

China ha encontrado el mayor depósito de oro de la historia y va a cambiarlo todo con ello

VOA News

Taiwan says China has launched biggest maritime operation in decades

The Times of India

Tata Power to invest Rs 1.2 lakh crore in Rajasthan

The Times of India

SoundHound: This AI stock rose 578% in 2024, how will it perform in 2025; why investors are gung-ho about this company? Here are its unique selling points

DIE WELT

Zinsen aus eingefrorenem russischen Vermögen – USA geben Kredit für Ukraine frei

Bitcoinist

These 7 Cryptos Could Explode This December, Say Specialists

Biztoc.com

Bill Gates: How Entrepreneurs Can Benefit From Climate Change

Noticiaslatam.lat

¿Cómo la industria automotriz de China podría afectar al mercado mundial del petróleo?

The Times of India

China sends largest naval fleet in decades to region, threat level severe, Taiwan says

The Daily Hodl

Trader Nets Over 10,000,000% in Profits on Dogecoin and Shiba Inu Competitor in Just 20 Months: Lookonchain

Biztoc.com

Israel captures Syrian territory after Assad regime collapse

$Galapagos Announces Encouraging New Results from Ongoing Phase 1/2 Study of CD19 CAR T-Cell Therapy, GLPG5101, in Patients with Relapsed/Refractory Non-Hodgkin Lymphoma$

GlobeNewswire

Galapagos Announces Encouraging New Results from Ongoing Phase 1/2 Study of CD19 CAR T-Cell Therapy, GLPG5101, in Patients with Relapsed/Refractory Non-Hodgkin Lymphoma